366-06-013 ISMRM Abstract

Comparative study of FOCUS MUSE and single-short EPI DWI for distinguishing lung adenocarcinoma from squamous cell carcinoma

Primary: Diffusion - DWI/DTI/DKI

Secondary: Body - Lung

366-06-013 · Body Diffusion MRI Applications · Monday, 11 May, 5:05 PM–6:00 PM · Digital Posters Row G

Keywords: Cancer Diffusion-Weighted Imaging Lung MRI

Accepted

Jie Li ¹, Jiankun Dai², Yi Xia¹

¹The Second Affiliated Hospital of Naval Medical University, SHANGHAI, China

²MR Research, Beijing, China

Presenting Author: Jie Li

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Wang W, Liu H, Li G. What’s the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients. Frontiers in Endocrinology. 2022;13. doi: 10.3389/fendo.2022.947443. [doi]

2. Bai Y, Pei Y, Liu WV, et al. MRI: Evaluating the Application of FOCUS-MUSE Diffusion-Weighted Imaging in the Pancreas in Comparison With FOCUS, MUSE, and Single-Shot DWIs. J Magn Reson Imaging. 2023;57(4):1156-1171. doi: 10.1002/jmri.28382. [doi]

3. Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243(2):570-577. doi: 10.1148/radiol.2432060131. [doi]

4. Usuda K, Iwai S, Yamagata A, et al. Relationships and Qualitative Evaluation Between Diffusion-Weighted Imaging and Pathologic Findings of Resected Lung Cancers. Cancers (Basel). 2020;12(5). doi: 10.3390/cancers12051194. [doi]

5. Feng P, Shao Z, Dong B, et al. Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer. Front Oncol. 2022;12:989131. doi: 10.3389/fonc.2022.989131. [doi]

6. Li G, Huang R, Zhu M, et al. Native T1-mapping and diffusion-weighted imaging (DWI) can be used to identify lung cancer pathological types and their correlation with Ki-67 expression. J Thorac Dis. 2022;14(2):443-454. doi: 10.21037/jtd-22-77. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/366-06-013